Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Management of metallic implants in radiotherapy: 2025 update
Abstract
The number of patients receiving radiotherapy while having metallic implants is steadily increasing. These implants degrade the quality of computed tomography images used throughout the radiotherapy process, including delineation, dosimetry, and dose delivery. This document presents the updated recommendations from the Société française de radiothérapie oncologique (SFRO; i.e., the French society for radiation oncology), outlining the advantages and limitations of various existing and emerging methods designed to reduce the impact of metallic implants on radiotherapy quality and safety.
Source and rights
Published by Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2025
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
- PubMed
- 40934609
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
